Combination fenofibrate plus simvastatin therapy in patients with::@0.040026:0.308083:0.795829:0.308083:0.795829:0.276293:0.040026:0.276293:0.020578:0.014272:0.022562:0.014272:0.006248:0.014657:0.012436:0.010126:0.006248:0.014272:0.014657:0.006573:0.009475:0.013531:0.014657:0.014272:0.007802:0.007802:0.014272:0.009890:0.012436:0.010126:0.013531:0.006573:0.014272:0.006307:0.014360:0.010541:0.006573:0.010541:0.006248:0.022562:0.012169:0.012436:0.010541:0.010126:0.012436:0.010126:0.006248:0.014657:0.006573:0.010126:0.014686:0.013531:0.009890:0.012436:0.014272:0.013798:0.006573:0.006248:0.014657:0.006573:0.014272:0.012436:0.010126:0.006248:0.013531:0.014657:0.010126:0.010541:0.006573:0.017884:0.006248:0.010126:0.014686:0.007580
Mixed dyslipidaemias  :@0.040026:0.352287:0.295109:0.352287:0.295109:0.320497:0.040026:0.320497:0.025257:0.006248:0.012347:0.013531:0.014272:0.006573:0.014272:0.013798:0.010541:0.006307:0.006248:0.014272:0.006248:0.014272:0.012436:0.013531:0.022562:0.006248:0.012436:0.010541:0.006573:0.006573
• :@0.040026:0.371520:0.053291:0.371520:0.053291:0.346794:0.040026:0.346794:0.008152:0.005113
Significantly improves TG, non-HDL-C and HDL-C levels vs simvastatin monotherapy (p < 0.001) :@0.053291:0.370580:0.812291:0.370580:0.812291:0.349386:0.053291:0.349386:0.010383:0.004165:0.009060:0.009771:0.004165:0.005201:0.005201:0.008705:0.008291:0.009771:0.006751:0.004204:0.009199:0.004382:0.004165:0.015041:0.009514:0.006534:0.009514:0.008113:0.009021:0.007027:0.004382:0.009199:0.014350:0.004599:0.004382:0.009771:0.009514:0.009771:0.007777:0.015081:0.014745:0.008804:0.007935:0.013956:0.004382:0.008291:0.009771:0.009514:0.004382:0.015081:0.014745:0.008804:0.007935:0.013956:0.004382:0.004204:0.009021:0.008113:0.009021:0.004204:0.007027:0.004382:0.008113:0.007027:0.004382:0.007027:0.004165:0.015041:0.008113:0.008291:0.007027:0.006751:0.008291:0.006751:0.004165:0.009771:0.004382:0.015041:0.009514:0.009771:0.009514:0.006751:0.009791:0.009021:0.006593:0.008291:0.009514:0.009199:0.004382:0.006613:0.009514:0.004382:0.008666:0.004382:0.012475:0.004066:0.012475:0.012475:0.006435:0.006790:0.004382
1 :@0.812279:0.363210:0.818585:0.363210:0.818585:0.350854:0.812279:0.350854:0.003752:0.002555
 :@0.040027:0.381295:0.042582:0.381295:0.042582:0.368939:0.040027:0.368939:0.002555
Type 2 diabetes mellitus  :@0.040026:0.418620:0.327768:0.418620:0.327768:0.386829:0.040026:0.386829:0.012969:0.013798:0.014272:0.013531:0.006573:0.015367:0.006573:0.014272:0.006248:0.012436:0.014272:0.013531:0.010126:0.013531:0.010541:0.006573:0.022562:0.013531:0.006307:0.006307:0.006248:0.010126:0.014360:0.010541:0.006573:0.006573
• Reduces CV events by 31 % vs simvastatin monotherapy :@0.040026:0.437844:0.559660:0.437844:0.559660:0.413118:0.040026:0.413118:0.008152:0.005113:0.014532:0.010524:0.011100:0.011169:0.010156:0.010524:0.008198:0.005113:0.016282:0.015291:0.005113:0.010524:0.009465:0.010524:0.011400:0.007876:0.008198:0.005113:0.011100:0.010732:0.005113:0.012252:0.007508:0.005113:0.015545:0.005113:0.009465:0.008198:0.005113:0.008198:0.004859:0.017548:0.009465:0.009672:0.008198:0.007876:0.009672:0.007876:0.004859:0.011400:0.005113:0.017548:0.011100:0.011400:0.011100:0.007876:0.011423:0.010524:0.007692:0.009672:0.011100:0.010732:0.005113
*3:@0.559648:0.429245:0.571195:0.429245:0.571195:0.414830:0.559648:0.414830:0.004404:0.007143
Lipanthyl  has a good safety profile in combination with a statin :@0.040272:0.497692:0.773338:0.497692:0.773338:0.465901:0.040272:0.465901:0.014538:0.006248:0.014272:0.012436:0.014657:0.010126:0.014686:0.013798:0.006307:0.014274:0.006573:0.014686:0.012436:0.010541:0.006573:0.012436:0.006573:0.013591:0.014272:0.014272:0.014272:0.006573:0.010541:0.012436:0.009475:0.013531:0.010126:0.013798:0.006573:0.014272:0.009801:0.014272:0.007802:0.007802:0.006307:0.013531:0.006573:0.006248:0.014657:0.006573:0.013058:0.014272:0.022562:0.014272:0.006248:0.014657:0.012436:0.010126:0.006248:0.014272:0.014657:0.006573:0.017884:0.006248:0.010126:0.014686:0.006573:0.012436:0.006573:0.010541:0.010126:0.012436:0.010126:0.006248:0.014657:0.006573
®:@0.147338:0.486636:0.161613:0.486636:0.161613:0.468102:0.147338:0.468102:0.014276
2:@0.773325:0.486636:0.782285:0.486636:0.782285:0.468102:0.773325:0.468102:0.008959
Dosage and directions for use: :@0.226993:0.558636:0.579785:0.558636:0.579785:0.526846:0.226993:0.526846:0.021792:0.014272:0.010541:0.012436:0.013591:0.013531:0.006573:0.012436:0.014657:0.014272:0.006573:0.014272:0.006248:0.009801:0.013531:0.013058:0.010126:0.006248:0.014272:0.014657:0.010541:0.006573:0.009475:0.014272:0.009890:0.006573:0.014360:0.010541:0.013531:0.007580:0.006573
4:@0.579779:0.547580:0.589894:0.547580:0.589894:0.529047:0.579779:0.529047:0.010116
  :@0.047286:0.614012:0.057511:0.614012:0.057511:0.589286:0.047286:0.589286:0.005113:0.005113
Adults:@0.057510:0.613073:0.107668:0.613073:0.107668:0.591879:0.057510:0.591879:0.013087:0.009514:0.009574:0.004204:0.006751:0.007027
One 200 mg capsule daily with food:@0.299417:0.612199:0.578967:0.612199:0.578967:0.591005:0.299417:0.591005:0.015969:0.009771:0.009021:0.004382:0.010245:0.012475:0.012475:0.004382:0.015041:0.009060:0.004382:0.008705:0.008291:0.009514:0.007027:0.009574:0.004204:0.009021:0.004382:0.009514:0.008291:0.004165:0.004204:0.009199:0.004382:0.011923:0.004165:0.006751:0.009791:0.004382:0.006317:0.009514:0.009514:0.009514
* In a subgroup of patients with TG ≥ 2,30 mmol/L + HDL-C ≤ 0,88 mmol/L :@0.039117:0.656896:0.431681:0.656896:0.431681:0.642767:0.039117:0.642767:0.004316:0.002922:0.003540:0.006514:0.002922:0.005527:0.002922:0.004685:0.006382:0.006343:0.006040:0.004356:0.006343:0.006382:0.006343:0.002922:0.006343:0.004211:0.002922:0.006343:0.005527:0.004501:0.002777:0.006014:0.006514:0.004501:0.004685:0.002922:0.007948:0.002777:0.004501:0.006527:0.002922:0.006132:0.009633:0.002922:0.005935:0.002922:0.006830:0.003066:0.007001:0.008317:0.002922:0.010028:0.010028:0.006343:0.002803:0.004211:0.006461:0.002922:0.006593:0.002922:0.010054:0.009830:0.005869:0.005290:0.009304:0.002922:0.005935:0.002922:0.008317:0.002948:0.007541:0.007541:0.002922:0.010028:0.010028:0.006343:0.002803:0.004211:0.006461:0.002922
 :@0.039117:0.668955:0.042038:0.668955:0.042038:0.654826:0.039117:0.654826:0.002922
TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol, CV, cardiovascular:@0.039117:0.681014:0.679450:0.681014:0.679450:0.666885:0.039117:0.666885:0.006132:0.009567:0.003066:0.002922:0.004501:0.004395:0.002777:0.006040:0.002803:0.006132:0.005803:0.006014:0.004395:0.002777:0.006343:0.006014:0.004685:0.003408:0.002922:0.010054:0.009830:0.005869:0.005290:0.009304:0.003066:0.002922:0.006527:0.002777:0.006040:0.006527:0.002922:0.006343:0.006014:0.006514:0.004685:0.002777:0.004501:0.006132:0.002922:0.002803:0.002777:0.006343:0.006343:0.006343:0.004356:0.006343:0.004501:0.006014:0.002777:0.006514:0.002922:0.005803:0.006527:0.006343:0.002803:0.006014:0.004685:0.004501:0.006014:0.004356:0.006343:0.002803:0.003408:0.002922:0.006461:0.009830:0.005869:0.005290:0.009304:0.003066:0.002922:0.002803:0.006343:0.007948:0.002922:0.006343:0.006014:0.006514:0.004685:0.002777:0.004501:0.006132:0.002922:0.002803:0.002777:0.006343:0.006343:0.006343:0.004356:0.006343:0.004501:0.006014:0.002777:0.006514:0.002922:0.005803:0.006527:0.006343:0.002803:0.006014:0.004685:0.004501:0.006014:0.004356:0.006343:0.002803:0.003066:0.002922:0.009304:0.008198:0.003066:0.002922:0.005803:0.005527:0.004395:0.006343:0.002777:0.006343:0.005409:0.005527:0.004685:0.005803:0.006382:0.002803:0.005527:0.004395
Reference: 1. :@0.038718:0.707869:0.096798:0.707869:0.096798:0.695321:0.038718:0.695321:0.007024:0.004836:0.003673:0.004836:0.003604:0.004836:0.005688:0.004617:0.004836:0.002798:0.002545:0.003823:0.002418:0.002545
Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J. Effectiveness and Tolerability of Simvastatin Plus Fenofibrate for Combined Hyperlipidemia :@0.096798:0.707781:0.773538:0.707781:0.773538:0.695418:0.096798:0.695418:0.008026:0.003558:0.005297:0.005412:0.005262:0.005078:0.002556:0.005849:0.009638:0.002395:0.002556:0.006471:0.004974:0.004997:0.004548:0.002556:0.008141:0.005366:0.002395:0.002556:0.005274:0.005297:0.004548:0.005412:0.002556:0.005861:0.002395:0.002556:0.006794:0.004548:0.003650:0.003650:0.002142:0.003811:0.003650:0.002142:0.002556:0.010064:0.005861:0.002395:0.002556:0.006759:0.003558:0.004548:0.005262:0.005078:0.002556:0.010064:0.006529:0.002395:0.002556:0.006264:0.004548:0.002165:0.008486:0.002142:0.003811:0.004548:0.005412:0.005262:0.002556:0.004376:0.002314:0.002556:0.006299:0.003420:0.003132:0.004974:0.004790:0.003650:0.002142:0.004445:0.004974:0.005412:0.004974:0.003811:0.003811:0.002556:0.004548:0.005412:0.005262:0.002556:0.004410:0.005262:0.002165:0.004974:0.003558:0.004548:0.005262:0.002142:0.002165:0.002142:0.003650:0.005078:0.002556:0.005262:0.003397:0.002556:0.005769:0.002142:0.008486:0.004445:0.004548:0.003811:0.003650:0.004548:0.003650:0.002142:0.005412:0.002556:0.006471:0.002165:0.005297:0.003811:0.002556:0.005884:0.004974:0.005412:0.005262:0.003034:0.002746:0.005262:0.003558:0.004548:0.003650:0.004974:0.002556:0.003397:0.005262:0.003558:0.002556:0.007715:0.005262:0.008486:0.005262:0.002142:0.005412:0.004974:0.005262:0.002556:0.008337:0.005078:0.005262:0.004974:0.003558:0.002165:0.002142:0.005262:0.002142:0.005262:0.004974:0.008486:0.002142:0.004836:0.002556
(The SAFARI Trial). Am J Cardiol 2005;95:462-468.   Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. The FIELD Study Investigators. Effects :@0.038718:0.718332:0.729897:0.718332:0.729897:0.705969:0.038718:0.705969:0.003673:0.005113:0.005423:0.004974:0.002556:0.005849:0.007346:0.006011:0.007346:0.007323:0.002959:0.002556:0.004537:0.003558:0.002142:0.004548:0.002165:0.003673:0.002314:0.002556:0.007346:0.008486:0.002556:0.004376:0.002556:0.007772:0.004548:0.003558:0.005262:0.002142:0.005262:0.002165:0.002556:0.005688:0.006989:0.006989:0.005849:0.002694:0.005965:0.005849:0.002660:0.006460:0.005965:0.005688:0.004410:0.006460:0.005965:0.006310:0.002314:0.002556:0.008095:0.002556:0.006483:0.004974:0.004974:0.004790:0.005423:0.002556:0.007346:0.002395:0.002556:0.005769:0.002142:0.008486:0.004974:0.003811:0.002556:0.007323:0.004376:0.002395:0.002556:0.006794:0.004548:0.003558:0.003650:0.004974:0.003558:0.002556:0.005861:0.002395:0.002556:0.006817:0.004974:0.003811:0.003650:0.002556:0.004376:0.002395:0.002556:0.005849:0.004790:0.005262:0.003650:0.003650:0.002556:0.007254:0.002395:0.002556:0.004295:0.004548:0.003811:0.004871:0.002142:0.005412:0.004974:0.005412:0.002556:0.009638:0.007254:0.002395:0.002556:0.004974:0.003650:0.002556:0.004548:0.002165:0.002314:0.002556:0.005113:0.005423:0.004974:0.002556:0.006264:0.002959:0.006529:0.005366:0.008314:0.002556:0.005677:0.003650:0.005297:0.005262:0.005078:0.002556:0.002810:0.005412:0.004445:0.004974:0.003811:0.003650:0.002142:0.004997:0.004548:0.003650:0.005262:0.003558:0.003811:0.002314:0.002556:0.006299:0.003420:0.003132:0.004974:0.004790:0.003650:0.004099:0.002556
2.:@0.272742:0.718420:0.281125:0.718420:0.281125:0.705873:0.272742:0.705873:0.005677:0.002706
of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised, controlled trial. Lancet :@0.038718:0.728884:0.707973:0.728884:0.707973:0.716521:0.038718:0.716521:0.005262:0.003397:0.002556:0.002165:0.005262:0.005412:0.004997:0.004468:0.003650:0.004974:0.003558:0.008486:0.002556:0.003397:0.004974:0.005412:0.005262:0.003034:0.002746:0.005262:0.003558:0.004548:0.003650:0.004974:0.002556:0.003650:0.005423:0.004974:0.003558:0.004548:0.005262:0.005078:0.002556:0.005262:0.005412:0.002556:0.004790:0.004548:0.003558:0.005262:0.002142:0.005262:0.004445:0.004548:0.003811:0.004790:0.005297:0.002165:0.004548:0.003558:0.002556:0.004974:0.004445:0.004974:0.005412:0.003650:0.003811:0.002556:0.002142:0.005412:0.002556:0.005930:0.005170:0.005965:0.005849:0.002556:0.005262:0.004974:0.005262:0.005262:0.002165:0.004974:0.002556:0.006667:0.002142:0.003650:0.005423:0.002556:0.003650:0.005078:0.005262:0.004974:0.002556:0.005688:0.002556:0.005262:0.002142:0.004548:0.005262:0.004974:0.003650:0.004974:0.003811:0.002556:0.008486:0.004974:0.002165:0.002165:0.002142:0.003650:0.005297:0.003811:0.002556:0.003466:0.003650:0.005423:0.004974:0.002556:0.006264:0.002959:0.006529:0.005366:0.008314:0.002556:0.003811:0.003650:0.005297:0.005262:0.004905:0.003673:0.002660:0.002556:0.003558:0.004548:0.005412:0.005262:0.005262:0.008486:0.002142:0.003811:0.004974:0.005262:0.002395:0.002556:0.004790:0.005262:0.005412:0.003650:0.003523:0.005262:0.002165:0.002165:0.004974:0.005262:0.002556:0.003650:0.003558:0.002142:0.004548:0.002165:0.002314:0.002556:0.005366:0.004548:0.005412:0.004790:0.004974:0.003938:0.002556
2005;366:1849-1861.  Elam MB, Lovato LC, Byington RP, et al. Hypertriglyceridemia and Low HDL-C Predicts Fenofibrate Response in The ACCORD-Lipid Trial. :@0.038718:0.739436:0.745661:0.739436:0.745661:0.727073:0.038718:0.727073:0.005688:0.006989:0.006989:0.005849:0.002694:0.005838:0.005965:0.005965:0.002660:0.003466:0.006310:0.006402:0.005965:0.004122:0.003466:0.006310:0.005884:0.003466:0.002314:0.002556:0.008141:0.006437:0.002165:0.004548:0.008486:0.002556:0.009638:0.006805:0.002395:0.002556:0.005331:0.005262:0.004445:0.004548:0.003650:0.005262:0.002556:0.005251:0.007853:0.002395:0.002556:0.006736:0.005078:0.002142:0.005412:0.004997:0.003650:0.005262:0.005412:0.002556:0.007323:0.005861:0.002395:0.002556:0.004974:0.003650:0.002556:0.004548:0.002165:0.002314:0.002556:0.008337:0.005078:0.005262:0.004974:0.003558:0.003650:0.003558:0.002142:0.004997:0.002165:0.005078:0.004790:0.004974:0.003558:0.002142:0.005262:0.004974:0.008486:0.002142:0.004548:0.002556:0.004548:0.005412:0.005262:0.002556:0.005331:0.005262:0.006667:0.002556:0.008509:0.008314:0.004848:0.004341:0.007853:0.002556:0.006322:0.003523:0.004974:0.005262:0.002142:0.004790:0.003650:0.003811:0.002556:0.005884:0.004974:0.005412:0.005262:0.003034:0.002746:0.005262:0.003558:0.004548:0.003650:0.004974:0.002556:0.006978:0.004974:0.003811:0.005262:0.005262:0.005412:0.003811:0.004974:0.002556:0.002142:0.005412:0.002556:0.005113:0.005423:0.004974:0.002556:0.007300:0.007818:0.007818:0.009166:0.007323:0.008187:0.004249:0.005366:0.002142:0.005262:0.002142:0.005262:0.002556:0.004537:0.003558:0.002142:0.004548:0.002165:0.002602:0.002556
3.:@0.137618:0.739524:0.146046:0.739524:0.146046:0.726976:0.137618:0.726976:0.005723:0.002706
Circ 2010;122:A19724.:@0.038718:0.749987:0.139287:0.749987:0.139287:0.737624:0.038718:0.737624:0.007761:0.002142:0.003512:0.004790:0.002556:0.005688:0.006989:0.003431:0.006989:0.002694:0.003466:0.005688:0.005688:0.002660:0.007346:0.003466:0.005930:0.005170:0.005539:0.006460:0.002602
 4. :@0.138999:0.750075:0.153093:0.750075:0.153093:0.737528:0.138999:0.737528:0.002545:0.006586:0.002418:0.002545
Lipanthyl  Package Insert. Abbott Laboratories (Pty) Ltd, South Africa. 23 September 2005.:@0.153093:0.749987:0.547693:0.749987:0.547693:0.737624:0.153093:0.737624:0.005366:0.002142:0.005262:0.004548:0.005412:0.003650:0.005423:0.005078:0.002453:0.004230:0.002556:0.006264:0.004548:0.004790:0.004825:0.004548:0.004997:0.004974:0.002556:0.002810:0.005412:0.003811:0.004974:0.003558:0.003650:0.002314:0.002556:0.007346:0.005262:0.005262:0.005262:0.003650:0.003650:0.002556:0.005366:0.004548:0.005262:0.005262:0.003558:0.004548:0.003650:0.005262:0.003558:0.002142:0.004974:0.003811:0.002556:0.003673:0.006517:0.003650:0.004905:0.003673:0.002556:0.005251:0.003650:0.005262:0.002395:0.002556:0.005849:0.005262:0.005297:0.003650:0.005423:0.002556:0.007220:0.003397:0.003558:0.002142:0.004790:0.004548:0.002314:0.002556:0.005688:0.005838:0.002556:0.005849:0.004974:0.005262:0.003650:0.004974:0.008486:0.005262:0.004974:0.003558:0.002556:0.005688:0.006989:0.006989:0.005849:-0.201504
®:@0.191274:0.745688:0.196825:0.745688:0.196825:0.738480:0.191274:0.738480:0.005552
S3   LipanthyL 200 mg capSuLeS.:@0.038803:0.781730:0.218697:0.781730:0.218697:0.769182:0.038803:0.769182:0.006103:0.005723:0.002314:0.002314:0.002395:0.005757:0.003547:0.006310:0.007577:0.008843:0.005711:0.008797:0.006655:0.005504:0.002545:0.005677:0.006920:0.006920:0.002625:0.009995:0.008060:0.002625:0.007818:0.007577:0.005896:0.006183:0.008221:0.005757:0.006713:0.006103:0.002706
 Pack size/s: 30 capsules. Each capsule contains 200 mg fenofibrate (micronised). Pharmacological classification a :@0.218409:0.781642:0.700735:0.781642:0.700735:0.769279:0.218409:0.769279:0.002556:0.006264:0.004548:0.004790:0.004871:0.002556:0.003811:0.002142:0.003915:0.004974:0.003213:0.003811:0.002660:0.002556:0.005838:0.006989:0.002556:0.004790:0.004548:0.005262:0.003811:0.005297:0.002165:0.004974:0.003811:0.002314:0.002556:0.006391:0.004548:0.004790:0.005423:0.002556:0.004790:0.004548:0.005262:0.003811:0.005297:0.002165:0.004974:0.002556:0.004790:0.005262:0.005412:0.003650:0.004548:0.002142:0.005412:0.003811:0.002556:0.005688:0.006989:0.006989:0.002556:0.008486:0.004997:0.002556:0.003397:0.004974:0.005412:0.005262:0.003034:0.002746:0.005262:0.003558:0.004548:0.003650:0.004974:0.002556:0.003547:0.008486:0.002142:0.004790:0.003523:0.005262:0.005412:0.002142:0.003811:0.004974:0.005262:0.003673:0.002314:0.002556:0.006471:0.005423:0.004548:0.003558:0.008486:0.004548:0.004790:0.005262:0.002165:0.005262:0.004997:0.002142:0.004790:0.004548:0.002165:0.002556:0.004790:0.002165:0.004548:0.003811:0.003811:0.002142:0.003034:0.002746:0.004790:0.004548:0.003650:0.002142:0.005262:0.005412:0.002556:0.004836:0.002556
7.5 serum cholesterol reducers. Registration number 30/7.5/0494. Namibia: NS2. 10/7.5/0333. For full prescribing information refer to the package insert :@0.038722:0.792194:0.697787:0.792194:0.697787:0.779831:0.038722:0.779831:0.005170:0.002257:0.005849:0.002533:0.003811:0.004974:0.003558:0.005297:0.008486:0.002533:0.004790:0.005423:0.005262:0.002165:0.004974:0.003811:0.003650:0.004974:0.003523:0.005262:0.002165:0.002533:0.003523:0.004974:0.005262:0.005297:0.004790:0.004974:0.003558:0.003811:0.002314:0.002533:0.006978:0.004974:0.004997:0.002142:0.003811:0.003650:0.003558:0.004548:0.003650:0.002142:0.005262:0.005412:0.002533:0.005412:0.005297:0.008486:0.005262:0.004974:0.003558:0.002533:0.005838:0.006989:0.003397:0.005170:0.002257:0.005849:0.003339:0.006989:0.006402:0.005965:0.006460:0.002314:0.002533:0.008406:0.004548:0.008486:0.002142:0.005262:0.002142:0.004548:0.002660:0.002533:0.008624:0.005849:0.005688:0.002314:0.002533:0.003431:0.006989:0.003397:0.005170:0.002257:0.005849:0.003339:0.006955:0.005838:0.005838:0.005838:0.002314:0.002533:0.005872:0.005262:0.003558:0.002533:0.003397:0.005297:0.002165:0.002165:0.002533:0.005262:0.003523:0.004974:0.003811:0.004790:0.003558:0.002142:0.005262:0.002142:0.005412:0.004997:0.002533:0.002142:0.005412:0.003397:0.005262:0.003558:0.008486:0.004548:0.003650:0.002142:0.005262:0.005412:0.002533:0.003523:0.004974:0.003397:0.004974:0.003558:0.002533:0.003650:0.005262:0.002533:0.003650:0.005423:0.004974:0.002533:0.005262:0.004548:0.004790:0.004825:0.004548:0.004997:0.004974:0.002533:0.002142:0.005412:0.003811:0.004974:0.003558:0.003938:0.002556
approved by the Medicines Regulatory Authority. Further information is available on request from the holder of the registration. Abbott Laboratories :@0.038722:0.802745:0.667158:0.802745:0.667158:0.790382:0.038722:0.790382:0.004548:0.005262:0.005262:0.003523:0.005262:0.004445:0.004974:0.005262:0.002556:0.005262:0.005078:0.002556:0.003650:0.005423:0.004974:0.002556:0.009546:0.004974:0.005262:0.002142:0.004790:0.002142:0.005412:0.004974:0.003811:0.002556:0.006978:0.004974:0.004997:0.005297:0.002165:0.004548:0.003650:0.005262:0.003639:0.005078:0.002556:0.007266:0.005297:0.003650:0.005423:0.005262:0.003558:0.002142:0.003650:0.004905:0.002314:0.002556:0.005907:0.005297:0.003558:0.003650:0.005423:0.004974:0.003558:0.002556:0.002142:0.005412:0.003397:0.005262:0.003558:0.008486:0.004548:0.003650:0.002142:0.005262:0.005412:0.002556:0.002142:0.003811:0.002556:0.004548:0.004445:0.004548:0.002142:0.002165:0.004548:0.005262:0.002165:0.004974:0.002556:0.005262:0.005412:0.002556:0.003523:0.004974:0.005262:0.005297:0.004974:0.003811:0.003650:0.002556:0.003397:0.003523:0.005262:0.008486:0.002556:0.003650:0.005423:0.004974:0.002556:0.005423:0.005262:0.002165:0.005262:0.004974:0.003558:0.002556:0.005262:0.003397:0.002556:0.003650:0.005423:0.004974:0.002556:0.003523:0.004974:0.004997:0.002142:0.003811:0.003650:0.003558:0.004548:0.003650:0.002142:0.005262:0.005412:0.002314:0.002556:0.007346:0.005262:0.005262:0.005262:0.003650:0.003650:0.002556:0.005366:0.004548:0.005262:0.005262:0.003558:0.004548:0.003650:0.005262:0.003558:0.002142:0.004974:0.004099:0.002556
S.A. (Pty) Ltd. Co. Reg. No. 1940/014043/07. Abbott Place, 219 Golf Club Terrace, Constantia Kloof, 1709. Tel: (011) 858 2000. Date of :@0.038722:0.813297:0.633800:0.813297:0.633800:0.800934:0.038722:0.800934:0.005792:0.002314:0.007346:0.002314:0.002556:0.003673:0.006517:0.003650:0.004905:0.003673:0.002556:0.005251:0.003650:0.005262:0.002314:0.002556:0.007715:0.005262:0.002314:0.002556:0.006978:0.004974:0.004928:0.002314:0.002556:0.008406:0.005262:0.002314:0.002556:0.003466:0.005965:0.006460:0.006989:0.003339:0.006989:0.003466:0.006460:0.006989:0.006460:0.005838:0.003339:0.006897:0.005170:0.002314:0.002556:0.007346:0.005262:0.005262:0.005262:0.003650:0.003650:0.002556:0.006471:0.002165:0.004548:0.004790:0.004974:0.002395:0.002556:0.005688:0.003466:0.005965:0.002556:0.008060:0.005262:0.002165:0.003397:0.002556:0.007772:0.002165:0.005297:0.005262:0.002556:0.004422:0.004974:0.003558:0.003558:0.004548:0.004790:0.004974:0.002395:0.002556:0.007715:0.005262:0.005412:0.003811:0.003650:0.004548:0.005412:0.003650:0.002142:0.004548:0.002556:0.006621:0.002165:0.005262:0.005262:0.003339:0.002395:0.002556:0.003466:0.005113:0.006989:0.005965:0.002314:0.002556:0.004422:0.004974:0.002165:0.002660:0.002556:0.003500:0.006989:0.003466:0.003466:0.003673:0.002556:0.006310:0.005849:0.006310:0.002556:0.005688:0.006989:0.006989:0.006989:0.002314:0.002556:0.008152:0.004548:0.003650:0.004974:0.002556:0.005262:0.003685:0.002556
Publication of this promotional material: June 2019.  Promo. No. ZAELIL190123:@0.038722:0.823849:0.379453:0.823849:0.379453:0.811486:0.038722:0.811486:0.006345:0.005297:0.005262:0.002165:0.002142:0.004790:0.004548:0.003650:0.002142:0.005262:0.005412:0.002556:0.005262:0.003397:0.002556:0.003650:0.005423:0.002142:0.003811:0.002556:0.005262:0.003523:0.005262:0.008486:0.005262:0.003650:0.002142:0.005262:0.005412:0.004548:0.002165:0.002556:0.008486:0.004548:0.003650:0.004974:0.003558:0.002142:0.004548:0.002165:0.002660:0.002556:0.004376:0.005297:0.005412:0.004974:0.002556:0.005688:0.006989:0.003466:0.005965:0.002314:0.002556:0.002556:0.006322:0.003523:0.005262:0.008486:0.005262:0.002314:0.002556:0.008406:0.005262:0.002314:0.002556:0.005861:0.007346:0.006529:0.005366:0.002959:0.005366:0.003466:0.005965:0.006989:0.003466:0.005688:0.006126